Expression of Ezrin,HGF,C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats

被引:7
|
作者
Xing-Guo Tan and Zhu-Lin Yang Research Laboratory of Hepatobiliary Diseases
机构
关键词
pancreatic neoplasms; animal model; Ezrin; hepatocyte growth factor; C-met;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
摘要
BACKGROUND:Recent studies have confirmed that the expression of Ezrin,hepatocyte growth factor(HGF)and its receptor(C-met)is related to the genesis,progress,invasion and metastasis of some malignant tumors.Researches have also found that the biological function of Ezrin is closely related to HGF/C-met in malignant tumors.However,there is no report on the expression levels of Ezrin,HGF and C-met in rat pancreatic cancer induced by dimethylbenzanthracene (DMBA).This study aimed to detect the expression of Ezrin, HGF and C-met in rat pancreatic cancer and non-cancerous pancreatic tissues,and assess its effect in cancer induction by DMBA. METHODS:Ninety Sprague-Dawley rats were divided into 3 groups randomly:40 in a pancreatic cancer model group (group A),40 in a trichostatin A(TSA)intervention group (group B),and 10 in a control group(group C).DMBA was directly implanted into the parenchyma of rat pancreas in group A+group B.The rats of group B were treated with 1 ml of TSA saline solution(1μg/ml)via intraperitoneal injection weekly.The carcinogenesis of rats executed within 3-5 months in groups A and B was observed by macrograph and microscopy. Meanwhile,the rats in group C were executed within 5 months. The EnVision TM immunohistochemistry for detecting the expression levels of Ezrin,HGF and C-met was used in paraffinembedded sections of the pancreatic specimens. RESULTS:The incidence of pancreatic cancer in group A was 48.6%and in group B 33.3%.The maximal diameter of tumor mass was significantly larger in group A than that in group B(P<0.05).No pathological changes were observed , in the pancreas of group C and other main organs of groups A and B.The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma than in non- cancerous pancreatic tissues of groups A and B(P<0.01).The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma of group A than those in non- cancerous pancreatic tissues of group A(P<0.05),but there was no significant difference in group B(P>0.05).The positive rates of Ezrin,HGF and C-met in non-cancerous pancreatic tissues proved mild to severe atypical hyperplasia of the ductal epithelia.The pancreas of group C and 2 cases of fibrosarcoma showed the negative expression of Ezrin,HGF and C-met.There was a trend of consistency in the expression of Ezrin,HGF and C-met in ductal adenocarcinoma(P<0.05 or P<0.01). CONCLUSIONS:DMBA directly implanted into the parenchyma of the pancreas can produce a model of pancreatic cancer with a high incidence in a short time.TSA might inhibit the carcinogenesis and growth of pancreatic cancer,and its effects may be related to the inhibition of the expression of Ezrin,HGF and C-met during the process.Ezrin,HGF and C-met may have positive effects on the carcinogenesis of rat pancreas.
引用
收藏
页码:639 / 644
页数:6
相关论文
共 50 条
  • [31] Expression of HGF/c-Met in control and keratoconus corneas
    You, J.
    Roufas, A.
    Wen, L.
    Hodge, C.
    Sutton, G.
    Madigan, M.
    ACTA OPHTHALMOLOGICA, 2014, 92
  • [32] Consistent expression of HGF and c-met in the perinatal lung
    Lassus, P.
    Janer, J.
    Haglund, C.
    Karikoski, R.
    Andersson, L. C.
    Andersson, S.
    BIOLOGY OF THE NEONATE, 2006, 90 (01): : 28 - 33
  • [33] Expression of c-Met and HGF in non-small cell lung carcinomas
    I. V. Korobko
    M. V. Zinov’eva
    E. P. Kopantsev
    A. K. Allakhverdiev
    I. B. Zborovskaya
    E. D. Sverdlov
    Molecular Genetics, Microbiology and Virology, 2007, 22 (2) : 59 - 63
  • [34] Combination of chemotherapy and c-MET inhibitors has synergistic effects in c-MET overexpressing pancreatic cancer cells
    Moosavi, Fatemeh
    Firoozi, Roya
    Tavakkoli, Marjan
    Nazari, Somayeh
    Alipour, Alireza
    Firuzi, Omidreza
    BIOCHIMIE, 2025, 231 : 73 - 83
  • [35] Hepatocyte growth factor (HGF) and c-Met expression in metastatic endometrial cancer
    Brieieva, O.
    Movchan, O.
    Buchynska, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S1352 - S1352
  • [36] C-met protooncogene expression and its regulation by cytokines in the regenerating pancreas and in pancreatic cancer cells
    Otte, JM
    Kiehne, K
    Schmitz, F
    Fölsch, UR
    Herzig, KH
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (01) : 90 - 95
  • [37] Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment
    Rucki, Agnieszka A.
    Xiao, Qian
    Muth, Stephen
    Chen, Jianlin
    Che, Xu
    Kleponis, Jennifer
    Sharma, Rajni
    Anders, Robert A.
    Jaffee, Elizabeth M.
    Zheng, Lei
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (11) : 2399 - 2409
  • [38] Endogenous carotenoid concentrations in cancerous and non-cancerous tissues of gastric cancer patients
    Lee, KS
    Yeum, KJ
    Paiva, SAR
    Lee-Kim, YC
    Russell, RM
    FASEB JOURNAL, 1998, 12 (05): : A856 - A856
  • [39] Overexpression of c-met in the early stage of pancreatic carcinogenesis;: altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer
    Yu, Jun
    Ohuchida, Kenoki
    Mizumoto, Kazuhiro
    Ishikawa, Nami
    Ogura, Yasuhiro
    Yamada, Daisuke
    Egami, Takuya
    Fujita, Hayato
    Ohashi, Seiji
    Nagai, Eishi
    Tanaka, Masao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (24) : 3878 - 3882
  • [40] Overexpression of c-met in the early stage of pancreatic carcinogenesis;altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer
    Kenoki Ohuchida
    Kazuhiro Mizumoto
    Nami Ishikawa
    Yasuhiro Ogura
    Daisuke Yamada
    Takuya Egami
    Hayato Fujita
    Seiji Ohashi
    Eishi Nagai
    Masao Tanaka
    World Journal of Gastroenterology, 2006, (24) : 3878 - 3882